0000000000742980

AUTHOR

Ian J. Cohen

showing 2 related works from this author

Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.

2003

In individuals with non-neuronopathic Gaucher disease, childhood manifestations are usually predictive of a more severe phenotype. Although children with Gaucher disease are at risk of irreversible disease complications, early intervention with an optimal dose of enzyme therapy can prevent the development of complications and ensure adequate, potentially normal, development through childhood and adolescence. Very few, if any, children diagnosed by signs and symptoms should go untreated. Evidence suggests that disease severity, disease progression and treatment response in different organs where glucocerebroside accumulates are often non-uniform in affected individuals. Therefore, serial mon…

AdultPediatricsmedicine.medical_specialtyConsensusBone diseaseAdolescentGenotypeAnemiaHepatosplenomegalyDiseaseGlucocerebrosideCentral nervous system diseaseQuality of lifemedicineHumansChildAgedGaucher Diseasebusiness.industryAge FactorsInfantMiddle Agedmedicine.diseasenon-neuronopathic Gaucher diseaseChild PreschoolPediatrics Perinatology and Child HealthImmunologyQuality of Lifemedicine.symptombusinessGlucocerebrosidaseEuropean journal of pediatrics
researchProduct

Early access experience with VPRIV®: Recommendations for ‘core data’ collection

2011

Pathologymedicine.medical_specialtyGaucher DiseaseData collectionProcess managementbusiness.industryData CollectionCell BiologyHematologyRecombinant ProteinsCell LineCore (game theory)Practice Guidelines as TopicGlucosylceramidaseHumansMolecular MedicineMedicineEnzyme Replacement TherapybusinessMolecular BiologyBlood Cells, Molecules, and Diseases
researchProduct